ICLR
NEUTRALAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Strong defensive value; Graham Number suggests significant upside if fundamentals stabilize.
- P/B < 1.0
- Price below Graham Number
- Low Forward P/E
- Intrinsic value based on growth is significantly lower ($51.94)
Growth metrics are currently non-existent or destructive.
- Analyst target price ($131.92) remains above current price
- Negative earnings growth
- Flat revenue growth
- High PEG ratio
Historical consistency has been erased by recent quarterly performance.
- Long history of meeting/beating estimates prior to 2025
- Severe 5-year price decline (-45%)
- Recent massive earnings surprise miss (-98.7%)
Financial structure is very healthy and low-risk regarding insolvency.
- Piotroski F-Score 7/9
- Low Debt/Equity (0.38)
- Current ratio > 1.0
- Altman Z-Score not provided
Not a dividend-paying stock.
- No dividend paid
- 0/100 dividend strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ICLR and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ICLR
ICON Public Limited Company
Primary
|
-45.0% | -49.2% | -25.1% | -41.8% | +1.4% | -6.5% |
|
ATR
AptarGroup, Inc.
Peer
|
-3.9% | +15.9% | -20.1% | -21.4% | +2.6% | +1.0% |
|
BTSG
BrightSpring Health Services, Inc.
Peer
|
+298.8% | +298.8% | +153.9% | +54.4% | +3.9% | +3.0% |
|
CYTK
Cytokinetics, Incorporated
Peer
|
+170.7% | +87.1% | +81.9% | +8.8% | +4.9% | -0.7% |
|
AVTR
Avantor, Inc.
Peer
|
-61.5% | -48.8% | -46.0% | -17.0% | +4.6% | -3.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q3 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ICLR
ICON Public Limited Company
|
NEUTRAL | $8.31B | 14.39 | 6.3% | 7.4% | $106.81 | |
|
ATR
AptarGroup, Inc.
|
NEUTRAL | $8.3B | 19.97 | 15.6% | 11.5% | $126.0 | Compare |
|
BTSG
BrightSpring Health Services, Inc.
|
NEUTRAL | $8.43B | 91.4 | 5.9% | 1.5% | $43.87 | Compare |
|
CYTK
Cytokinetics, Incorporated
|
NEUTRAL | $8.06B | - | -% | -% | $65.48 | Compare |
|
AVTR
Avantor, Inc.
|
BEARISH | $8.05B | - | -1.5% | -1.2% | $11.8 | Compare |
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning ICLR from our newsroom.